EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy

Gabriel Pasquarelli-do-Nascimento, Sabrina Azevedo Machado, Juliana Maria Andrade de Carvalho, Kelly Grace Magalhães iD

Immunotherapy Advances · 01.01.2022 · 2 (1)

DOI: 10.1093/immadv/ltac015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 24.06.2022. Verfasst von Gabriel Pasquarelli-do-Nascimento und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, DF, Brazil. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many different types of cancer are now well known to have increased occurrence or severity in individuals with obesity. The influence of obesity on cancer and the immune cells in the tumor microenvironment has been thought to be a pleiotropic effect. As key endocrine and immune organs, the highly plastic adipose tissues play crucial roles in obesity pathophysiology, as they show alterations according to environmental cues. Adipose tissues of lean subjects present mostly anti-inflammatory cells that are crucial in tissue remodeling, favoring uncoupling protein 1 expression and non-shivering thermogenesis. Oppositely, obese adipose tissues display massive proinflammatory immune cell infiltration, dying adipocytes, and enhanced crown-like structure formation. In this review, we discuss how obesity can lead to derangements and dysfunctions in antitumor CD8+ T lymphocytes dysfunction. Moreover, we explain how obesity can affect the efficiency of cancer immunotherapy, depicting the mechanisms involved in this process. Cancer immunotherapy management includes monoclonal antibodies targeting the immune checkpoint blockade. Exhausted CD8+ T lymphocytes show elevated programmed cell death-1 (PD-1) expression and highly glycolytic tumors tend to show a good response to anti-PD-1/PD-L1 immunotherapy. Although obesity is a risk factor for the development of several neoplasms and is linked with increased tumor growth and aggressiveness, obesity is also related to improved response to cancer immunotherapy, a phenomenon called the obesity paradox. However, patients affected by obesity present higher incidences of adverse events related to this therapy. These limitations highlight the necessity of a deeper investigation of factors that influence the obesity paradox to improve the application of these therapies.

Schlagwörter

Stichwörter der Autor:innen

adipose tissuecancerimmunotherapyobesity

Autor:innen und Institutionen

  • Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, DF, Brazil.

ORCID-Profile: Kelly Grace Magalhães

Zitieren

APA

Pasquarelli-do-Nascimento, G., Machado, S. A., de Carvalho, J. M. A., & Magalhães, K. G. (2022). Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy. Immunotherapy Advances, 2(1). https://doi.org/10.1093/immadv/ltac015

Vancouver

Pasquarelli-do-Nascimento G, Machado SA, de Carvalho JMA, Magalhães KG. Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy. Immunotherapy Advances. 2022;2(1). doi:10.1093/immadv/ltac015

BibTeX
@article{PasquarellidoNascimento2022,
  author = {Pasquarelli-do-Nascimento, Gabriel and Machado, Sabrina Azevedo and de Carvalho, Juliana Maria Andrade and Magalhães, Kelly Grace},
  title = {Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy},
  journal = {Immunotherapy Advances},
  year = {2022},
  volume = {2},
  number = {1},
  doi = {10.1093/immadv/ltac015}
}
Kostenlos starten →